Development of an effective meropenem/KPC-2 inhibitor combination to combat infections caused by carbapenem-resistant Klebsiella pneumoniae.
Int J Antimicrob Agents
; 64(3): 107268, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38972552
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Klebsiella Infections
/
Microbial Sensitivity Tests
/
Carbapenem-Resistant Enterobacteriaceae
/
Meropenem
/
Klebsiella pneumoniae
/
Anti-Bacterial Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Int J Antimicrob Agents
Year:
2024
Document type:
Article
Country of publication: